Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Health Care Supplies

CytoSorbents Corp

+ Add to Watchlist

CTSO:US

7.4500 USD 0.0500 0.67%

As of 20:10:00 ET on 04/17/2015.

Snapshot for CytoSorbents Corp (CTSO)

Open: 7.4400 Day's Range: 7.3200 - 7.5200 Volume: 135,415
Previous Close: 7.5000 52wk Range: 4.4000 - 15.2400 1-Yr Rtn: +35.45%

Stock Chart for CTSO

No chart data available.
  • CTSO:US 7.4500
  • 1D
  • 1M
  • 1Y
7.5000
Interactive CTSO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CTSO

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.5000
Est. EPS (USD) (12/2015) -0.3770
Est. PEG Ratio -
Market Cap (M USD) 183.55
Shares Outstanding (M) 24.64
30 Day Average Volume 477,912
Price/Book (mrq) 43.8081
Price/Sale (ttm) 148.4616
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/14/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CTSO

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CTSO

CytoSorbents Corp. is involved in the research, development and commercialization of medical devices with its platform blood purification technology. The Company focuses on developing this technology for multiple applications in the medical field for the treatment of acute and chronic health complications associated with blood toxicity.

Phillip ChanPresident/CEOKathleen P Bloch "Kathy"Chief Financial Officer
Vincent CapponiChief Operating OfficerRobert BartlettChief Medical Officer
More Company Profile & Key Executives for CTSO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil